 Home > Medical News > Latest Medical News > Qilu Pharmaceutical's new anti-cancer drug imported for USD 235 million applied for clinical application

Qilu Pharmaceutical's new anti-cancer drug imported for USD 235 million applied for clinical application

 Last Update: 2021-06-05
 Source: Internet
 Author: User

Tags

drug overdose videos

drug interaction website

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Pharmaceutical Guanlan

According to the announcement of the Center for Drug Evaluation (CDE) of the State Drug Administration of China, Qilu Pharmaceutical submitted a clinical trial application for CEND-1 for injection, which was accepted on May 27.

Screenshot source: CDE official website

CEND-1, also known as iRGD, is a polypeptide that can bind to neuropilin.

On February 16, Cend and Qilu Pharmaceutical announced that they had reached a cooperation.

According to Cend’s official website, CEND-1 is intended to be developed for the treatment of pancreatic cancer and triple-negative breast cancer.

Note: The original text has been deleted

Reference materials:

[1] Drug Evaluation Center of China National Medical Products Administration.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.